LMND.NYSELemonade, INC

Form 4: Lemonade Chief Insurance Officer Executes Pre-Planned Stock Option Exercise and Share Sale

Sentiment:

Insider Transaction Report


Lemonade, Inc.'s Chief Insurance Officer, John Sheldon Peters, exercised stock options and subsequently sold an equivalent number of common shares on June 23, 2025, as part of a pre-arranged trading plan.

Summary

  • John Sheldon Peters, the Chief Insurance Officer of Lemonade, Inc. (LMND), reported transactions on June 23, 2025.
  • He acquired 6,543 shares of Lemonade common stock by exercising fully vested stock options at an exercise price of $5.26 per share.
  • Concurrently, Mr. Peters disposed of 6,543 shares of common stock at a sale price of $45.00 per share.
  • The sale was executed under a Rule 10b5-1 trading plan, which was adopted on August 30, 2024.
  • Following these transactions, Mr. Peters beneficially owns 106,115 shares of common stock and 28,457 stock options.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. While an insider sale can be seen negatively, the fact it's a 10b5-1 plan and the officer still holds a significant number of shares/options, combined with the substantial profit on the exercised options, makes it less concerning than an unannounced, large-scale sale.

Positives

  • The exercise of stock options indicates the officer is realizing value from their compensation package.
  • The sale was conducted under a Rule 10b5-1 plan, suggesting a pre-scheduled transaction rather than a reaction to immediate market conditions or negative news.
  • The sale price of $45.00 per share is significantly higher than the exercise price of $5.26, indicating a substantial gain for the officer on these specific shares.

Negatives

  • An insider sale, even when pre-planned, can sometimes be perceived negatively by the market as it reduces the officer's direct equity stake in the company.

Future Outlook

The document does not provide forward-looking statements or guidance regarding the company's future performance or strategic direction, focusing solely on an insider trading activity.

Industry Context

This Form 4 filing is specific to an individual insider's transaction and does not provide broader industry context or trends. However, insider sales, even pre-planned, are routinely monitored by investors for insights into management's perception of valuation, particularly in the insurance technology (insurtech) sector where Lemonade operates.

Stakeholder Impact

  • Shareholders: May interpret the sale as a signal, though the execution under a Rule 10b5-1 plan mitigates immediate concerns. The officer still retains significant holdings, indicating continued alignment with shareholder interests.

Key Dates

DateDescription
08/30/2024Date Rule 10b5-1 trading plan was adopted.
06/23/2025Date of stock option exercise and common stock sale.
06/25/2025Date Form 4 was signed by the attorney-in-fact.
03/27/2028Expiration date of the stock option.

Recommendation

hold

Keywords

Lemonade Inc., LMND, SEC Form 4, Insider Trading, Stock Options, Share Sale, John Sheldon Peters, Chief Insurance Officer, 10b5-1 Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.